• the significant complications and death influenza produces among the chronically ill.
• the under-diagnosis of influenza in favor of bacterial diagnoses, and the resulting over-prescription of antibiotics.
• the protection of the medically vulnerable in hospitals and nursing homes.

The ZymeTx program can be used by physicians, provider groups, managed care and other payer groups, and quality program organizations (NCQA, JCAHO). It fulfills the mandate to increase healthcare quality and decrease costs, while increasing patient satisfaction.

The ZymeTx program identifies at-risk groups. It provides education and communication programs that encourage vaccination, early recognition of symptoms, and definitive diagnosis of influenza. It suggests possible antiviral treatment to prevent complications that could lead to hospitalization and death. The program provides a guideline for influenza management. It provides an educational program for physicians and patients to aid their awareness that influenza, during its season, is the most common cause of respiratory symptoms. It should be thought of first - before bacterial disease.

• Provides education to patients regarding the expected course of influenza illness and why antibiotics are not used to treat viral infections.
• Includes influenza control measures for vulnerable individuals in need of protection.
• Includes surveillance measures designed to alert the physician's own practice and the community that influenza is in the area and precautions should be taken.